<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Korea Aesthetic Journal</title>
    <link>https://koreaaestheticjournal.com/</link>
    <description>Clinical reading of aesthetic medicine in Korea</description>
    <language>en</language>
    <atom:link href="https://koreaaestheticjournal.com/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>Botulinum Toxin Type-A — Korean Brand Clinical Survey 2026</title>
      <link>https://koreaaestheticjournal.com/botulinum-toxin-type-a-korean-brands-clinical-survey/</link>
      <guid>https://koreaaestheticjournal.com/botulinum-toxin-type-a-korean-brands-clinical-survey/</guid>
      <description>A journal-of-medicine reading of the Korean botulinum toxin type-A landscape in 2026 — what MFDS clearance distinguishes between Hutox, Nabota, Coretox, Meditoxin, Wonder-Tox, and Liztox, and how the senior Seoul houses sequence the unit count, the dilution, and the four-week review around an intern</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Downtime by Procedure — Clinical Survey 2026</title>
      <link>https://koreaaestheticjournal.com/downtime-by-procedure-clinical-survey-2026/</link>
      <guid>https://koreaaestheticjournal.com/downtime-by-procedure-clinical-survey-2026/</guid>
      <description>A journal-of-medicine reading of what aesthetic-procedure downtime actually looks like in Seoul in 2026 — by procedure category, by recovery milestone, and by the calendar a serious international traveller would build a Korean visit around.</description>
      <pubDate>2026-05-25T11:00:00Z</pubDate>
    </item>
    <item>
      <title>Juvelook (PDLLA) + MFU Combination — A Korean Clinical Reading</title>
      <link>https://koreaaestheticjournal.com/juvelook-pdlla-mfu-combination-clinical-reading/</link>
      <guid>https://koreaaestheticjournal.com/juvelook-pdlla-mfu-combination-clinical-reading/</guid>
      <description>A journal-of-medicine reading of the Juvelook PDLLA microsphere booster stacked with microfocused ultrasound lifting in Korea in 2026 — what the published literature actually shows about the layered protocol, what the MFDS clearance record permits, and how senior Seoul houses sequence biostimulation</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Rejuran vs Plinest — Polynucleotide Clinical Comparison 2026</title>
      <link>https://koreaaestheticjournal.com/rejuran-vs-plinest-polynucleotide-clinical-comparison-2026/</link>
      <guid>https://koreaaestheticjournal.com/rejuran-vs-plinest-polynucleotide-clinical-comparison-2026/</guid>
      <description>A journal-of-medicine reading of the two anchor polynucleotide skin boosters available in Korea in 2026 — Rejuran from Pharma Research and Plinest from Mastelli — with attention to molecular source, polymer weight, MFDS clearance, and how senior Seoul houses sequence each protocol at the chair.</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Non-Surgical Nose Augmentation in Korea — A 2026 Clinical Reading</title>
      <link>https://koreaaestheticjournal.com/non-surgical-nose-augmentation-clinical-reading-2026/</link>
      <guid>https://koreaaestheticjournal.com/non-surgical-nose-augmentation-clinical-reading-2026/</guid>
      <description>A clinical-literature reading of non-surgical nose augmentation as practised in Korean clinics in 2026 — what the dorsum, tip, and columellar protocols actually do, what the vascular-safety record looks like, and what the regulatory and consent picture is for an international patient.</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Korean Lifting-Device Grade System (MFDS Class) — 2026 Reading</title>
      <link>https://koreaaestheticjournal.com/lifting-device-grade-system-korea-2026/</link>
      <guid>https://koreaaestheticjournal.com/lifting-device-grade-system-korea-2026/</guid>
      <description>An editorial reading of how Korean regulators stratify lifting devices — Class II versus Class III medical-device clearance, energy modality, depth, and what the grade actually means for a senior Korean clinical protocol.</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Carbon Laser / Q-Switched Devices — Clinical Categorization 2026</title>
      <link>https://koreaaestheticjournal.com/carbon-laser-q-switch-clinical-device-categorization-2026/</link>
      <guid>https://koreaaestheticjournal.com/carbon-laser-q-switch-clinical-device-categorization-2026/</guid>
      <description>Carbon-laser toning rests on a quiet pulse-duration distinction — Q-switched Nd:YAG nanosecond at 1064 nm versus picosecond 1064 nm — and the Korean clinical literature reads the two as mechanistically related but operationally separate device classes.</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Post-MFU Recovery: A Clinical Protocol Reading 2026</title>
      <link>https://koreaaestheticjournal.com/post-mfu-recovery-clinical-protocol-2026/</link>
      <guid>https://koreaaestheticjournal.com/post-mfu-recovery-clinical-protocol-2026/</guid>
      <description>Micro-focused ultrasound delivers its visible result on a 90-to-180-day collagen timetable — yet the recovery phase that reads most reliably is the one a Korean senior house has rehearsed many times. The clinical literature reads recovery as five overlapping windows, each with its own biomarker.</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Hydrodermabrasion / Aqua Peel — Device Categorization and Clinical Reading</title>
      <link>https://koreaaestheticjournal.com/hydrodermabrasion-aqua-peel-clinical-categorization/</link>
      <guid>https://koreaaestheticjournal.com/hydrodermabrasion-aqua-peel-clinical-categorization/</guid>
      <description>Hydrodermabrasion, often marketed in Korea as aqua peel, hydro peel, or hydrafacial, is a category of vacuum-assisted serum-infusion devices that exfoliate the stratum corneum while delivering aqueous serums into the upper dermis. The clinical literature reads four distinct platforms in this categor</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Post-Injection Bruising and Vascular Events — Clinical Reading 2026</title>
      <link>https://koreaaestheticjournal.com/post-injection-bruising-vascular-clinical-reading-2026/</link>
      <guid>https://koreaaestheticjournal.com/post-injection-bruising-vascular-clinical-reading-2026/</guid>
      <description>A journal-of-medicine reading of the post-injection complication spectrum in Korea in 2026 — what the published literature describes about routine bruising, Tyndall effect, vascular occlusion, and impending necrosis, and how senior Seoul houses script the hyaluronidase, nitroglycerin, and antibiotic</description>
      <pubDate>2026-05-25T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Thread Lift in Korea — A 2026 Clinical Reading</title>
      <link>https://koreaaestheticjournal.com/thread-lift-korea-clinical-reading/</link>
      <guid>https://koreaaestheticjournal.com/thread-lift-korea-clinical-reading/</guid>
      <description>A journal-of-medicine reading of the thread-lift procedure as practised in Korean clinics in 2026 — what the literature supports, what the regulatory record shows, and what the candid recovery curve actually looks like for an international patient.</description>
      <pubDate>2026-05-23T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Exosome vs PDRN vs Skin Booster — A Korean Clinical Comparison</title>
      <link>https://koreaaestheticjournal.com/exosome-pdrn-skin-booster-clinical-comparison/</link>
      <guid>https://koreaaestheticjournal.com/exosome-pdrn-skin-booster-clinical-comparison/</guid>
      <description>A journal-of-medicine reading of the regenerative trio in Korea in 2026 — what the published literature actually shows about exosome paracrine signalling, PDRN tissue repair, and the broader skin-booster category, and how senior Seoul houses sequence each protocol distinctly in the consultation room</description>
      <pubDate>2026-05-24T10:00:00Z</pubDate>
    </item>
    <item>
      <title>PDO vs PCL vs PLLA Thread Lifts: A Korean Clinical Categorization</title>
      <link>https://koreaaestheticjournal.com/pdo-vs-pcl-vs-pla-thread-categorization/</link>
      <guid>https://koreaaestheticjournal.com/pdo-vs-pcl-vs-pla-thread-categorization/</guid>
      <description>A clinical reading of the three absorbable suture polymers used in Korean thread-lift practice — PDO, PCL, and PLLA — read against the published material-science literature, the MFDS device register, and the recovery curves the senior Korean houses actually document.</description>
      <pubDate>2026-05-24T11:00:00Z</pubDate>
    </item>
    <item>
      <title>PDLLA Microsphere Clinical Evidence — A 2026 Korean Survey</title>
      <link>https://koreaaestheticjournal.com/pdlla-microsphere-clinical-evidence-survey-2026/</link>
      <guid>https://koreaaestheticjournal.com/pdlla-microsphere-clinical-evidence-survey-2026/</guid>
      <description>A journal-of-medicine reading of PDLLA microsphere biostimulators in Korea in 2026 — what the published literature actually shows, what the MFDS clearance record covers, and how senior Seoul houses sequence the protocol for an international patient.</description>
      <pubDate>2026-05-24T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Stem Cell Aesthetic Medicine in Korea — Regulatory Class &amp; Clinical Reading</title>
      <link>https://koreaaestheticjournal.com/stem-cell-aesthetic-medicine-regulatory-class-korea/</link>
      <guid>https://koreaaestheticjournal.com/stem-cell-aesthetic-medicine-regulatory-class-korea/</guid>
      <description>A journal-of-medicine reading of the Korean stem cell aesthetic regulatory framework — the MFDS class assignment, the MOHW Advanced Regenerative Medicine Center designation pathway, the autologous-versus-cultured-versus-exosome distinction, and the small group of Seoul practices the literature and t</description>
      <pubDate>2026-05-24T11:00:00Z</pubDate>
    </item>
    <item>
      <title>Ultherapy Prime vs Thermage FLX vs Sofwave — A Korean Triple Clinical Comparison</title>
      <link>https://koreaaestheticjournal.com/ultherapy-thermage-sofwave-triple-clinical-comparison/</link>
      <guid>https://koreaaestheticjournal.com/ultherapy-thermage-sofwave-triple-clinical-comparison/</guid>
      <description>Three lifting platforms, three mechanisms, three depth profiles. The Korea Aesthetic Journal reads MFU, RF, and SUPERB ultrasound side by side — not as a ranking, but as a categorical clinical comparison the Korean senior practice has converged on.</description>
      <pubDate>2026-05-24T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Ultherapy Prime in Korea: A Clinical Reading of MFU Device Categorization</title>
      <link>https://koreaaestheticjournal.com/ultherapy-prime-mfu-device-categorization/</link>
      <guid>https://koreaaestheticjournal.com/ultherapy-prime-mfu-device-categorization/</guid>
      <description>Ultherapy Prime is the Merz Aesthetics fourth-generation micro-focused ultrasound platform. The clinical literature reads it as a SMAS-targeting device — and the categorization question, in Korea, turns on what &#x27;MFU-V&#x27; actually denotes in practice.</description>
      <pubDate>2026-05-24T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Thermage FLX Monopolar RF — A Korean Clinical Reading</title>
      <link>https://koreaaestheticjournal.com/thermage-flx-monopolar-rf-clinical-reading/</link>
      <guid>https://koreaaestheticjournal.com/thermage-flx-monopolar-rf-clinical-reading/</guid>
      <description>Thermage FLX is the Solta Medical fourth-generation monopolar radiofrequency platform. The clinical literature reads it as a volumetric dermal-heating device — and the Korean protocol question turns on tip generation, vibration delivery, and how the AccuREP algorithm adapts pulse-to-pulse to the ski</description>
      <pubDate>2026-05-24T10:00:00Z</pubDate>
    </item>
    <item>
      <title>Sofwave SUPERB Intense Ultrasound — A Korean Clinical Categorization</title>
      <link>https://koreaaestheticjournal.com/sofwave-superb-ultrasound-device-categorization/</link>
      <guid>https://koreaaestheticjournal.com/sofwave-superb-ultrasound-device-categorization/</guid>
      <description>Sofwave is the Sofwave Medical synchronous-ultrasound platform built on the SUPERB delivery architecture — seven parallel ultrasound beams heating the mid-dermis in a single pass. The clinical literature reads it as a dermal-collagen device, not an SMAS-lifting device, and the categorization questio</description>
      <pubDate>2026-05-24T10:00:00Z</pubDate>
    </item>
  </channel>
</rss>
